Biological Activities of Secondary Metabolites from the Edible-Medicinal Macrofungi

Xiaoqi Sun,Ying Shi,Dongxiao Shi,Yu Tu,Ling Liu
DOI: https://doi.org/10.3390/jof10020144
2024-02-11
Journal of Fungi
Abstract:Macrofungi are well-known as edible-medicinal mushrooms, which belong mostly to Basidiomycota, with a few from Ascomycota. In recent years, macrofungi have been recognized as a rich resource of structurally unique secondary metabolites, demonstrating a wide range of bioactivities, including anti-tumor, antioxidant, anti-inflammatory, antimicrobial, antimalarial, neuro-protective, hypoglycemic, and hypolipidemic activities. This review highlights over 270 natural products produced by 17 families of macrofungi covering 2017 to 2023, including their structures, bioactivities, and related molecular mechanisms.
microbiology,mycology
What problem does this paper attempt to address?